خط مشی دسترسیدرباره ما
ثبت نامثبت نام
راهنماراهنما
فارسی
ورودورود
صفحه اصلیصفحه اصلی
جستجوی مدارک
تمام متن
منابع دیجیتالی
رکورد قبلیرکورد بعدی
library name : انستیتو تغذیه دانشگاه علوم پزشکی شهید بهشتی
Material Type : Latin Articles
Language of Document : English
Record Number : 62029
Doc. No : 688A
Main Entry : MAHDAVI MAZDEH M
Title & Author : MANAGEMENT OF CALCIUM AND PHOSPHORUS METABOLISM IN HEMODIALYSIS PATIENTS IN TEHRAN PROVINCE, IRAN [Article]; HEYDARI ROUCHI A.R.
Title : IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD)
Volume Number : , Vol.1 ؛ No.1
Date : , (2007)
page : : 25 - 28
Abstract : Introduction: Our aim was to evaluate the degree of achievement of the recommended values in National Kidney Foundation Dialysis Outcomes Quality Initiative )K/DOQI( guidelines for the laboratory indicators of bone metabolism in patients undergoing hemodialysis )HD( in Tehran province.Materials and Methods: We evaluated the laboratory information of 2630 HD patients in Tehran province. Demographic data of the patients and the clinical information including the duration of dialysis session, dialysate calcium concentration, Kt/V, and serum values of calcium, phosphorus, and intact parathyroid hormone )PTH( were recorded. The laboratory values were compared to the recommended ranges by the K/DOQI work group in patients with end-stage renal disease.Results: Only 1.8percent of the patients could enjoy a successful management according to the K/DOQI recommendations for the 4 target laboratory tests of serum calcium, phosphorus, intact parathyroid hormone, and calcium-phosphorus product. Hypocalcemia was diagnosed in 33.2percent of the patients, whereas 13.6percent were diagnosed with hypercalcemia. Hypophosphatemia and secondary hyperparathyroidism were diagnosed in 6.8percent and 24.2percent of the patients, respectively.Conclusions: Our findings proved that complying with the recommendations established by the K/DOQI work group in the clinical management of mineral metabolism is very demanding. Phosphate binders frequently lead to untoward toxicities and imbalance in bone metabolism of patients on HD, warranting new cost-effective therapies with fewer side effects. It would be of great interest to analyze, in the future, the benefits derived from the effect of new therapies such as calcimimetics or new phosphate binders regarding the achievement of the K/DOQI guidelines.
Descriptor : BONE METABOLISM
Descriptor : CHRONIC KIDNEY DISEASE
Descriptor : CALCIUM
Descriptor : PHOSPHORUS
Descriptor : PARATHYROID
Descriptor : HEMODIALYSIS
Added Entry : ZAMYADI M
: NOUROUZI SH
 
 
 
(در صورت عدم وضوح تصویر اینجا را کلیک نمایید)